Enzo Biochem, Inc. ($0.01 Par Value) (ENZ): Price and Financial Metrics
ENZ Price/Volume Stats
| Current price | $1.09 | 52-week high | $2.74 |
| Prev. close | $1.13 | 52-week low | $1.07 |
| Day low | $1.07 | Volume | 258,100 |
| Day high | $1.12 | Avg. volume | 98,436 |
| 50-day MA | $1.27 | Dividend yield | N/A |
| 200-day MA | $1.37 | Market Cap | 55.84M |
ENZ Stock Price Chart Interactive Chart >
Enzo Biochem, Inc. ($0.01 Par Value) (ENZ) Company Bio
Enzo Biochem, Inc. engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company was founded in 1976 and is based in New York, New York.
Latest ENZ News From Around the Web
Below are the latest news stories about ENZO BIOCHEM INC that investors may wish to consider to help them evaluate ENZ as an investment opportunity.
ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATEFARMINGDALE, NY, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fourth quarter ended July 31, 2023, and the fiscal year ended July 31, 2023, and also provided a general business update. Fourth Quarter Highlights In July 2023, Enzo Biochem closed on the sale of assets used in the operation of Enzo Clinical Labs for a cash purchase price of $113,250,000, resulting in the full divestment of Enzo’s clinical laborat |
Steven J. Pully Appointed to Enzo Biochem’s Board of DirectorsFARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading life sciences company, announced today that Steven J. Pully has been appointed to the Company’s Board of Directors effective October 26, 2023. Mr. Pully will assume the role of Chairperson of the Board, and Chair of the Audit Committee as well. “In 2023, Enzo completed the divestiture of Enzo Clinical Labs, Inc. and focused its strategy on growing the life sciences division,” sai |
Enzo Biochem (NYSE:ENZ) shareholders have endured a 63% loss from investing in the stock five years agoGenerally speaking long term investing is the way to go. But unfortunately, some companies simply don't succeed. For... |
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEOFARMINGDALE, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of Directors and departing the Company effective September 5, 2023, with Enzo’s Chief Operating Officer, Kara Cannon, assuming the role of interim CEO. “We thank Hamid for the commitment he has brought to Enzo Biochem, Inc.” Chairperson of the Board Mary Tagliaferri, MD stated, “Hamid successfully led the Co |
Here’s Why Laughing Water Capital Made a Position in Enzo Biochem (ENZ)Laughing Water Capital, an investment management company, released its second-quarter 2023 investor letter. A copy of the same can be downloaded here. In the second quarter, investment in the fund returned 13.8%, net of all fees and expenses, compared to the SP500TR and the R2000 returns of 8.7% and 5.2%, respectively. The fund’s return so far […] |
ENZ Price Returns
| 1-mo | -9.92% |
| 3-mo | -19.85% |
| 6-mo | -20.44% |
| 1-year | -57.75% |
| 3-year | -65.83% |
| 5-year | -69.97% |
| YTD | -21.58% |
| 2023 | -2.80% |
| 2022 | -55.45% |
| 2021 | 27.38% |
| 2020 | -4.18% |
| 2019 | -5.40% |
Continue Researching ENZ
Want to do more research on Enzo Biochem Inc's stock and its price? Try the links below:Enzo Biochem Inc (ENZ) Stock Price | Nasdaq
Enzo Biochem Inc (ENZ) Stock Quote, History and News - Yahoo Finance
Enzo Biochem Inc (ENZ) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...